NTI 2.82% 6.9¢ neurotech international limited

Ann: Neurotech Receives Additional HREC Approval in Autism, page-3

  1. 548 Posts.
    lightbulb Created with Sketch. 106
    The quote I liked from Dr Duthy was where he said the fact there have been no side effects and he has seen such significant progress in his patients.

    If the phase II/III trial is going the same way....would have to assume it is....then this company could really be onto something even just for an autism treatment.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
6.9¢
Change
-0.002(2.82%)
Mkt cap ! $70.19M
Open High Low Value Volume
7.0¢ 7.1¢ 6.9¢ $28.78K 414.5K

Buyers (Bids)

No. Vol. Price($)
5 227441 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 74000 1
View Market Depth
Last trade - 14.12pm 25/07/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.